Tafaleng, Edgar N <br/><br/>
Induced pluripotent stem cells model personalized variations in liver disease resulting from α1-antitrypsin deficiency.  [electronic resource] 

 -  Hepatology (Baltimore, Md.)  Jul 2015 
 - 147-57 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1527-3350 
<br/><br/><label>Standard No.: </label>10.1002/hep.27753  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cells, Cultured<br/>Endoplasmic Reticulum, Rough--metabolism<br/>Humans<br/>Induced Pluripotent Stem Cells--metabolism<br/>Liver Diseases--etiology<br/>alpha 1-Antitrypsin--metabolism<br/>alpha 1-Antitrypsin Deficiency--complications